Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
Status:
Terminated
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
This 6-month extension study will provide further information regarding the long-term safety
and tolerability of intepirdine (RVT-101) in subjects with Dementia with Lewy bodies (DLB)
who have participated in the double-blind, placebo-controlled, lead-in study RVT-101-2001.